Tumor samples from CRC patients have been shown to display lower immunopositivity rates than nontransformed tissue, and ACKR4 protein expression was positively correlated with patients’ survival [19], while transcriptomic analysis of a small set of clinical samples did not show significant differences [18]. This evidence concerns the gene ACKR4 and colorectal carcinoma.